Abstract
Gloriosa superba: L. (G. superba) is a perennial creeper and climbs up to 5-7 meters. It belongs to the Liliaceae family and is native to Africa and South-East Asia. It is also categorized as an endangered plant which may be due to its extensive use.
Objective: The objective of the present review is to explore anticancer potential with other pharmacological activities of G. superba and its active constituents.
Results: G. superba has been reported to have many chemical constituents including colchicine, β- sitosterol, glumicolchicine, b-lumicolchicine, 2-OH-6-MeO-benzoic acid, glorisine, tannins, colchicoside, cornigerine, and many more. Most of them are effective against cancer, gout, arthritis, ulcers, bleeding piles, impotence, snakebites, skin diseases, and leprosy. G. superba has also been reported to possess pharmacological activities like anticancer, anti-inflammatory, antioxidant, abortifacient, anti-ulcerogenic, anti-helminthic and antimicrobial.
Conclusion: The present review summarizes the anticancer potential of G. superba and its constituents. However, a detailed study is required to establish it as an effective anticancer drug.
Keywords: Gloriosa superba l., anticancer, colchicine, anti-inflammatory, colchicoside, conigerine.
Graphical Abstract
The Natural Products Journal
Title:A Retrospective Study on Gloriosa superba and Its Main Active Constituents
Volume: 11 Issue: 4
Author(s): Aishwarya Shriwastava, Vijay Chopra, Manish Vyas*, Gopal L. Khatik, Pramod Yadav, Jeena Gupta and Amrit Pal Singh
Affiliation:
- Department of Ayurveda, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara,India
Keywords: Gloriosa superba l., anticancer, colchicine, anti-inflammatory, colchicoside, conigerine.
Abstract:
Gloriosa superba: L. (G. superba) is a perennial creeper and climbs up to 5-7 meters. It belongs to the Liliaceae family and is native to Africa and South-East Asia. It is also categorized as an endangered plant which may be due to its extensive use.
Objective: The objective of the present review is to explore anticancer potential with other pharmacological activities of G. superba and its active constituents.
Results: G. superba has been reported to have many chemical constituents including colchicine, β- sitosterol, glumicolchicine, b-lumicolchicine, 2-OH-6-MeO-benzoic acid, glorisine, tannins, colchicoside, cornigerine, and many more. Most of them are effective against cancer, gout, arthritis, ulcers, bleeding piles, impotence, snakebites, skin diseases, and leprosy. G. superba has also been reported to possess pharmacological activities like anticancer, anti-inflammatory, antioxidant, abortifacient, anti-ulcerogenic, anti-helminthic and antimicrobial.
Conclusion: The present review summarizes the anticancer potential of G. superba and its constituents. However, a detailed study is required to establish it as an effective anticancer drug.
Export Options
About this article
Cite this article as:
Shriwastava Aishwarya, Chopra Vijay , Vyas Manish *, Khatik L. Gopal , Yadav Pramod , Gupta Jeena and Singh Pal Amrit , A Retrospective Study on Gloriosa superba and Its Main Active Constituents, The Natural Products Journal 2021; 11 (4) . https://dx.doi.org/10.2174/2210315510999200704141949
DOI https://dx.doi.org/10.2174/2210315510999200704141949 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Drug Design for Gene Therapy - Taking Advantage of Introns
Letters in Drug Design & Discovery Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on the Baculovirus Systems
Recent Patents on Biotechnology Cell Penetrating Peptide Delivery of Splice Directing Oligonucleotides as a Treatment for Duchenne Muscular Dystrophy
Current Pharmaceutical Design Reactive Oxygen Species, Cancer and Anti-Cancer Therapies
Current Chemical Biology Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) Transdermal Oxandrolone: Ex Vivo Percutaneous Absorption Study
Current Drug Delivery Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
Endocrine, Metabolic & Immune Disorders - Drug Targets Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA Current Patents on Osteoinductive Molecules for Bone Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued) ThermoTRP Channels in Nociceptors: Taking a Lead from Capsaicin Receptor TRPV1
Current Neuropharmacology Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Current Medicinal Chemistry Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds
Medicinal Chemistry Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer
Anti-Cancer Agents in Medicinal Chemistry Recapitulation of Cancer Nanotherapeutics
Current Nanomedicine Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Advances in the Knowledge and Clinical Applications of Lactic Acid Bacteria as Probiotics in the Urogenital Tract
Current Women`s Health Reviews